Exogenous Control of the Expression of Group I CD1 MoleculesCompetent for Presentation of Microbial Nonpeptide Antigens toHuman T Lymphocytes

Abstract EN

Group I CD1 (CD1a, CD1b, and CD1c) glycoproteins expressed on immature and mature dendritic cells present nonpeptide antigens (i.e., lipid or glycolipid molecules mainly of microbial origin) to T cells.

Cytotoxic CD1-restricted T lymphocytes recognizing mycobacterial lipid antigens were found in tuberculosis patients.

However, thanks to a complex interplay between mycobacteria and CD1 system, M.

tuberculosis possesses a successful tactic based, at least in part, on CD1 downregulation to evade CD1-dependent immunity.

On the ground of these findings, it is reasonable to hypothesize that modulation of CD1 protein expression by chemical, biological, or infectious agents could influence host's immune reactivity against M.

tuberculosis-associated lipids, possibly affecting antitubercular resistance.

This scenario prompted us to perform a detailed analysis of the literature concerning the effect of external agents on Group I CD1 expression in order to obtain valuable information on the possible strategies to be adopted for driving properly CD1-dependent immune functions in human pathology and in particular, in human tuberculosis.